4
Changes in Ownership
RxSight, Inc. Filed Acc 0000950170-24-016515
Chief Operating Officer sold 25,000 shares at an average $54.00 ($1,350,000)
- Chief Operating Officer acquired 25,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Goldshleger Ilya Chief Operating Officer | 2024-02-14 | Option exercise 10b5-1 | +5,000 | $23.04 | $115,200 | 31,475 | D |
| Goldshleger Ilya Chief Operating Officer | 2024-02-14 | Sale 10b5-1 | −5,000 | $52.00 | $260,000 | 26,475 | D |
| Goldshleger Ilya Chief Operating Officer | 2024-02-15 | Option exercise 10b5-1 | +10,000 | $23.04 | $230,400 | 36,475 | D |
| Goldshleger Ilya Chief Operating Officer | 2024-02-15 | Sale 10b5-1 | −5,000 | $53.00 | $265,000 | 31,475 | D |
| Goldshleger Ilya Chief Operating Officer | 2024-02-15 | Sale 10b5-1 | −5,000 | $54.00 | $270,000 | 26,475 | D |
| Goldshleger Ilya Chief Operating Officer | 2024-02-16 | Option exercise 10b5-1 | +10,000 | $23.04 | $230,400 | 36,475 | D |
| Goldshleger Ilya Chief Operating Officer | 2024-02-16 | Sale 10b5-1 | −5,000 | $55.00 | $275,000 | 31,475 | D |
| Goldshleger Ilya Chief Operating Officer | 2024-02-16 | Sale 10b5-1 | −5,000 | $56.00 | $280,000 | 26,475 | D |
| Derivatives | |||||||
| Goldshleger Ilya Chief Operating Officer | 2024-02-14 | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 20,000 | D | ||
| Goldshleger Ilya Chief Operating Officer | 2024-02-15 | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 10,000 | D | ||
| Goldshleger Ilya Chief Operating Officer | 2024-02-16 | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 0 | D | ||
| Open-market sales · 25,000 sh · avg $54.00 · $1,350,000 | |||||||
Loading xslF345X05/ownership.xml…